Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Chronic myeloid neoplasms. Diagnostic criteria and current therapeutic concepts].

Der Pathologe - 1 Feb 2010

Schmitt-Graeff A H

Abstract excerpt

Myeloproliferative neoplasms (MPNs) and related chronic disorders constitute a subgroup of myeloid malignancies which are defined according to clinical, morphological and molecular features by the actual World Health Organization classification of tumors of the haematopietic system. Screening procedures for a BCR-ABL fusion gene, JAK2, thrombopoietin receptor and KIT mutations are formally included in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Share to Leukemia, Myelomonocytic, Chronic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Myeloproliferative Disorders

Share to Polycythemia Vera

Share to Primary Myelofibrosis

Share to Protein-Tyrosine Kinases

Source

Identifiers

PMID: 20076959
DOI: 10.1007/s00292-009-1261-x

Genes

JAK2
BCR
FGFR1
KIT
PDGFRA
PDGFRB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Chronic myeloid neoplasms. Diagnostic criteria and current therapeutic concepts].PMID 20076959Read ↗

Myeloid neoplasms in the World Health Organization 2016 classification.Semantic proximity Read ↗

The 2008 World Health Organization classification system for myeloproliferative neoplasmsSemantic proximity Read ↗

An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasmsSemantic proximity Read ↗

World Health Organization Classification, Evaluation, and Genetics of the Myeloproliferative Neoplasm VariantsSemantic proximity Read ↗

[Myeloproliferative neoplasms (including chronic myeloid leukemia)].Semantic proximity Read ↗

Biology and Current Treatment of Myeloproliferative Neoplasms.Semantic proximity Read ↗

[Current diagnosis of myeloproliferative neoplasms (2008 WHO classification)].Semantic proximity Read ↗

[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].Semantic proximity Read ↗

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.Semantic proximity Read ↗

The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.Semantic proximity Read ↗

Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms.Semantic proximity Read ↗

The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.